Triana Biomedicines
WALTHAM, MA · Biotechnology, Healthcare · 58 employees
TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel small molecules to treat disease. Our technology enables us to identify molecules that promote the interaction between a target and another protein in a way that alters the fate or function of the target protein. These innovative “molecular glues” allow us to treat dise
Funding history
- Venture - Series Unknown — $120.1M — Dec 2025
- Series B — $120.0M — Dec 2025
- Venture - Series Unknown — $42.6M — Apr 2022
- Venture - Series Unknown — $42.6M — Feb 2022
- Venture - Series Unknown — $10.0M — Sep 2021
Recent signals
- May 18, 2026: TRIANA Biomedicines Appoints Mohan Bala as Chief Operating Officer
- Dec 04, 2025: Raised $120.1M in Venture - Series Unknown
- Dec 03, 2025: Raised $120.0M in Series B
- Sep 12, 2023: TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer
- Apr 19, 2022: Raised $42.6M in Venture - Series Unknown
- Feb 11, 2022: Raised $42.6M in Venture - Series Unknown
- Sep 17, 2021: Raised $10.0M in Venture - Series Unknown
- Jul 06, 2020: Raised $6.0M in Venture - Series Unknown
See plans & pricing → Track Triana Biomedicines’s funding, hiring, and signals — with verified contacts — on Fundz.